BioRestorative Therapies Inc (BRTX)

[DiviningRod]

I'm afraid you'll hear about funding in the blurb they will write when they execute the R/S & share offer. If they can't boost price to ~ penny, they can still do it for less $, and/or with a larger dilution effect.

Someone has to pay for the trial-it will be whomever holds shares at the time that the music stops.

What irks me is that Mgt paid themselves in H1 far in excess of what they need for the clinical trial / build out, BUT expect shareholders to pay for it through an offer of some of their 300 billion shares 'cloaked' in an R/S. I hope this is not the end result for shareholders, but all indications are that this is the path this is on (IMO). It sucks!

I am fully out and only comment now in the hopes that someone may avoid a great loss in this POS.


GLTA